
Contract research organization (CRO) providing clinical trial management, regulatory compliance, and medical writing services for pharmaceuticals, medical devices, and biotechnology sectors.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
EmpCo Directive — September 27, 2026
We analyzed the websites of over 250,000 companies, including Alsinova's, to extract CSR initiatives and communications containing risky environmental claims.
Greenwashing risk score + your position within your sector
+250,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: September 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
Oncodesign Services
B
Contract research organization (CRO) specializing in drug discovery, focusing on oncology and inflammation. Services include target identification, small molecule development, molecular radiotherapy, biologics, and preclinical studies.
Axonal-Biostatem devient Heva
A
Clinical research organization (CRO) providing services for clinical trials, early access, and epidemiological studies.
Centaur Clinical CRO
B
Clinical research organization (CRO) providing full support for clinical trials, CE marking, post-market clinical follow-up (PMCF) and bioequivalence studies for pharmaceuticals, medical devices, IVDs and dietary supplements.
Initiatives identified among leaders
Amélioration des conditions de travail
“Amélioration des conditions de travail et de la qu...” - Axonal-Biostatem devient HevaAdoption de pratiques éthiques et durables
“Centaur Clinical CRO adopte des pratiques éthiques...” - Centaur Clinical CROMise en place d'une stratégie de Développement Durable
“Mise en place d'une stratégie de développement dur...” - Axonal-Biostatem devient Heva64% of similar organizations communicate on CSR issues
+186 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports